Navigation Links
Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams
Date:2/8/2010

PORTLAND, Ore., Feb. 8 /PRNewswire/ -- Prolifiq and viaLanguage today announced a partnership to enhance the use of localized content by sales teams. Together, the companies will offer a combined solution that reduces the time for translated content to reach the hands of global sales professionals and provide critical measurements of how localized assets accelerate the sales cycle. This combination gives the sales person the right information, individualized, to meet the needs and language of their clients and prospects.

Access to quality, up-to-date localized content is often burdensome and costly for companies. By reducing the cycle of time from content creation to content distribution, Prolifiq and viaLanguage will help businesses get to market faster and remain competitive. In addition, Prolifiq's Content Performance Index (CPI) provides companies with the data to know which translated content resonates with local sales teams and customers. Combining viaLanguage's Online Language System (OLS) enables fast turn around and skilled translations for each solution needed.

"Content sells, and with this partnership we now make it faster and easier for our Technology and Life Sciences customers to provide localized content to their global sales teams," said Jeff Gaus, CEO of Prolifiq. "And with CPI, they can maximize their investment and get localized content utilizing viaLanguage's experience by seeing, in real-time, what content their customers find most valuable."

"Working with Prolifiq will not only reduce the time it takes translated content to reach the field, but will allow us to provide to our customers critical visibility into the impact of our localized content on the sales process," said Chanin Ballance, CEO of viaLanguage. "Our set of online translation and localization services is geared to today's fast-paced, cross-cultural business environment, and the integrated workflow with Prolifiq is a natural extension of these services."

About Prolifiq

Prolifiq helps sales professionals use digital content in their communications with customers and prospects. Used in highly regulated environments such as Life Sciences and competitive industries such as Technology, Prolifiq's messaging solutions help sellers match approved content to their selling conversation, wrap it in branded messages and measure the effectiveness of their communications. Customers include: AtriCure, Cisco Systems, GE, The BBC, Associated Press, and Getty Images. For more information, visit www.prolifiq.net/lifesciences

About viaLanguage

viaLanguage is a leading provider of online language translation and localization services. Through the unique combination of its Online Language System (OLS), expert linguists and integration capabilities, viaLanguage offers organizations a comprehensive, affordable solution for meeting today's increasing need for effective multilingual communications. viaLanguage services are designed to help clients quickly and easily develop the very best multilingual websites, software applications, marketing materials and other global communications. Since 2000, the company has earned a reputation among its clients for reliability, quality and professionalism. Clients include: Blue Shield California, Regence, A-dec, Disney, BASF, Nike, and Citibank, as well as many hospitals, school districts and state governments. Corporate Headquarters are located at 700 SW Taylor Street, Suite 310, Portland, OR 97205.  For more information, visit www.vialanguage.com or call us at 503-243-2007.

Legal Notice: All rights reserved. Prolifiq is either a trademark or registered trademark and the Prolifiq logo is a trademark of Prolifiq Software, Inc. Product specifications are subject to change without notice.

SOURCE Prolifiq

RELATED LINKS
http://www.prolifiq.net
http://www.vialanguage.com

'/>"/>

SOURCE Prolifiq
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prolifiq and EthicsPoint Announce Partnership: Automatic Alerts Help Life Sciences Engage in Good Promotional Practices
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):